P
Piero Dalerba
Researcher at Columbia University
Publications - 60
Citations - 16901
Piero Dalerba is an academic researcher from Columbia University. The author has contributed to research in topics: Stem cell & Cancer stem cell. The author has an hindex of 30, co-authored 54 publications receiving 15541 citations. Previous affiliations of Piero Dalerba include Istituto Superiore di Sanità & Stanford University.
Papers
More filters
Journal ArticleDOI
Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models
Huiping Liu,Manishkumar Patel,Jennifer A. Prescher,Antonia Patsialou,Dalong Qian,Jiahui Lin,Susanna Wen,Ya Fang Chang,Ya Fang Chang,Michael Bachmann,Yohei Shimono,Piero Dalerba,Maddalena Adorno,Neethan A. Lobo,Janet Bueno,Frederick M. Dirbas,Sumanta Goswami,George Somlo,John S. Condeelis,Christopher H. Contag,Sanjiv S. Gambhir,Michael F. Clarke +21 more
TL;DR: These metastatic cancer models, combined with noninvasive imaging techniques, constitute an integrated approach that could be applied to dissect the molecular mechanisms underlying the dissemination of metastatic CSCs (MCSCs) and to explore therapeutic strategies targeting MCSCs in general or to evaluate individual patient tumor cells and predict response to therapy.
Journal ArticleDOI
CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer
Piero Dalerba,Debashis Sahoo,Soonmyung Paik,Xiangqian Guo,Greg Yothers,Nan Song,Nate Wilcox-Fogel,Erna Forgó,Pradeep S. Rajendran,Stephen P. Miranda,Shigeo Hisamori,Jacqueline Hutchison,Tomer Kalisky,Dalong Qian,Norman Wolmark,George A. Fisher,Matt van de Rijn,Michael F. Clarke +17 more
TL;DR: Lack of CDX2 expression identified a subgroup of patients with high-risk stage II colon cancer who appeared to benefit from adjuvant chemotherapy.
Journal ArticleDOI
Immunity to cancer: attack and escape in T lymphocyte–tumor cell interaction
Licia Rivoltini,Matteo Carrabba,Veronica Huber,Chiara Castelli,Luisa Novellino,Piero Dalerba,Roberta Mortarini,Giuseppe Arancia,Andrea Anichini,Stefano Fais,Giorgio Parmiani +10 more
TL;DR: This review discusses the possible anti‐T‐cell counterattack mediated by FasL‐positive tumor cells, and shows that FasL is located in the cytoplasm of melanoma cells and is transported in the tumor microenvironment through the release of melanosomes.
Journal ArticleDOI
Fusobacterium nucleatum promotes colorectal cancer by inducing Wnt/β-catenin modulator Annexin A1.
Mara Roxana Rubinstein,Jung Eun Baik,Stephen M. Lagana,Richard P Han,William J. Raab,Debashis Sahoo,Piero Dalerba,Timothy C. Wang,Yiping W. Han +8 more
TL;DR: A “two‐hit” model in colorectal carcinogenesis is proposed, with somatic mutation(s) serving as the first hit, and F. nucleatum as the second hit exacerbating cancer progression after benign cells become cancerous.
Journal ArticleDOI
Identification of a cKit+ Colonic Crypt Base Secretory Cell That Supports Lgr5+ Stem Cells in Mice
Michael E. Rothenberg,Ysbrand Nusse,Tomer Kalisky,John J. Lee,Piero Dalerba,Ferenc A. Scheeren,Neethan A. Lobo,Subhash Kulkarni,Sopheak Sim,Dalong Qian,Philip A. Beachy,Philip A. Beachy,Pankaj J. Pasricha,Stephen R. Quake,Stephen R. Quake,Michael F. Clarke +15 more
TL;DR: Four major epithelial subtypes or transcriptional states were revealed by gene expression analysis of selected populations of single cells, and cKit marks small intestinal Paneth cells and a subset of colonic goblet cells that are regulated by Notch signaling and support Lgr5(+) stem cells.